That is necessary, because the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and be efficient. Simply put, we have to understand how these proteins fold if we desire a drug to work. Historically, this has been a trial-and-error procedure (tech stock). Today, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're created to do. This was a breakthrough nearly nobody observed. But it's going to have extensive implications for curing illness. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, obviously, there will be a lot of financial investment chances in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech pick). That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be amazed if it drew back possibly significantly before going greater - jeff brown. I've been covering bitcoin for a long period of time now. Among the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. However that's not the huge question any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a relied on 170-year-old institution. So think about that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. angel investor. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These companies raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I predict 2021 will be another record year in IPOs. There are many fantastic personal business on the verge of striking the public markets And I've been dealing with a brand-new method for you to invest even before these companies go public.
This chance has actually been building over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the information. Go right here to reserve your area totally free.
Emma Walsh here, managing editor of the Journal. Routine Diary readers understand that tech isn't our usual beat (melania trump). And when it concerns tech investing, we leave it to the experts. Fortunately, we have a number of such experts in our Rolodex. Our colleague Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing specialists we understand (jeff brown genome sequencing). In reality, he had several triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to take a look at the huge picture and predict what's simply around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and much more. These patterns are experiencing rapid growth and producing amazing chances for investors. I want to ensure all our readers are prepared for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I have actually been covering for years now. jeff brown. But in spite of what numerous readers may believe, this is a pattern that's simply starting. Although the COVID-19 pandemic interfered with supply chains last year, an impressive 250 million 5G-enabled gadgets were still sold.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (melania trump). Losing 2 months of manufacturing and sales actually affects the number of 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million systems is remarkable. More importantly, the delays triggered by the pandemic produced a load of pent-up demand. And that need is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G gadgets will be shipped in 2021 - longtime readers. Which's not my only 5G prediction When I've discussed 5G in the past, I've explained its 3 various stages.
In Phase Two, 5G gadgets go on sale. 5G phones and other items begin to reach consumers. And in Phase 3, 5G services begin to be used (jeff brown stock market prediction). That's when we start to see applications operating on 5G networks. Consider things like massive multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Phase Three by this summer season. This begins something of a virtuous cycle: Many individuals do not actually appreciate the innovation. But they will care if there are amazing applications that can only be accessed with a 5G phone.
That causes more 5G apps being established. In truth, 5G is going to open up a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The investment opportunities moving forward will be huge. Stepping away from 5G, the next important innovation I visualize in 2021 is CRISPR genetic modifying. CRISPR represents "clustered regularly interspaced brief palindromic repeat." It's a mouthful. However it's one of the most exciting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our genetic makeup as if it were software application.
The program can crash or not work properly. CRISPR utilizes a similar idea however with our genetic code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For several years, CRISPR was primarily a specific niche innovation that wasn't well comprehended. And during that time, there were actually just three business running in this space. But things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're treating illness and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering unbelievable returns. This whole market is efficiently a greenfield opportunity.
There's room for lots of companies to exist in this space. future report review. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more genetic editing companies will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things occurring at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its most current Alpha, Fold software can properly anticipate the folding of a protein based exclusively on its amino acid series with 92. 4% precision. That is essential because the way a protein in the human body folds identifies if a pharmaceutical will have the ability to bind to that protein and be effective.
Historically, this has actually been an experimental procedure. However now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're developed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one however a number of drug therapies produced utilizing this technology. This was one of those breakthroughs that almost nobody discovered. However it's going to have profound ramifications for treating illness. And, of course, there will be lots of financial investment chances in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back possibly considerably prior to going higher. I have actually been covering bitcoin for a long period of time now. One of the very first research reports I ever released was on bitcoin - jeff brown biotech pick. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on financial investment for anyone who followed my suggestion. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time.
However no one is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. future report. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and declares the info depends on date as of February 2021, but we might not separately validate this claim. Given Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like ability to choose winning innovation stocks. He invested more than 25 years looking into innovation business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an excellent viewpoint on the marketplace. He's always on the hunt for brand-new opportunities, and he shares a number of his finest picks in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an exceptional credibility as a stock-picker, and he effectively forecasted a few of the greatest economic events of the previous twenty years. Although he does not appear to release his picks to the general public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it right each time, but Jeff Brown's precise predictions have earned him legions of dedicated followers. That states a lot about his capability. The Future Report is published by Brownstone Research study, a popular financial research publisher. Brownstone Research study provides numerous research services with a large range of specializations - first lady.
The business is likewise associated with Bonner & Partners, another well-respected research study publisher - jeff brown 2020 predictions. On its site, Brownstone says its objective is to offer retail investors with professional-grade research study: "For too long, the best investment research study has actually not been readily available to specific investors. It has actually been usually scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth customers. korean actress. The objective of Brownstone Research is to make that type of proprietary research study readily available to any investors wanting to gain an edge in the markets. The goal is basic to deliver unique and successful financial investment research study discovered no place else." -Brownstone Research website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also works as the company's Chief Investment Expert.
With Brown directing the ship, Brownstone Research is a powerhouse publisher with lots to offer its customers. After years of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a family name throughout most of America. If you know even a little bit about the marketplace, you know that he has a credibility as a King Midas of sorts. future report review. Whatever he touches turns to gold! Jeff is well aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge job.
In fact, Brown believes S.A.V. second wave. might be "the biggest pattern of the 2020s, and he's not alone. Examine out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding 2 advanced technologies: expert system and electrical cars and trucks. Musk hopes the mix will help him develop the first fully-autonomous, self-driving cars and trucks ever. It's absolutely nothing except the automotive industry's Holy Grail. As you know, electric cars and self-driving car stocks have actually been substantial this year, however the Wall Street machine has approved buzz without much tangible result. Regardless of a drastic increase in competition over the previous few years, Brown still believes Musk has the best possibility of putting everything together.
tech might be the magic string that connects everything together. S.A.V. represents Shared Autonomous Car, and it might be the future of transport. Generally, this innovation would allow you to rent your car as a self-governing, self-driving taxi when you're not using it. You merely leave the vehicle and press a button on an app that tells the car to "join the fleet." Next thing you understand, you're relaxing on your sofa while your car shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the profits. It sounds insane, however it could be closed than you think.